March 15, 2021
Mayo Clinic Research in the news — 3/15/2021
News stories this week about Mayo Clinic research and highlighting researchers cover several topics including research education, examining the retina to detect dementia, lumbar punctures and opioid management. State leaders stress the importance of phase II of Prairie Springs Science Center WXOW, 3/9/2021 Seven state leaders gathered at UW-La Crosse’s Crowley Hall Tuesday morning to […]
Tags: Alzheimer's disease, Amy Oxentenko, cancer, Center for Clinical and Translational Science, clinical trials, COVID-19, David Knopman, dementia, Derek Johnson, diabetes, Mayo Clinic Alix School of Medicine, Mayo Clinic Health System
February 16, 2021
Mayo Clinic Research in the news — 2/15/2021
By Advancing the Science contributor
Mayo Clinic research and faculty were highlighted in a range of articles over the last week. Headlines and links below to stories on research collaborations and expansions, as well as specific disease advancements, and all the latest COVID-19 news and information. Ionic liquid formulation can uniformly deliver chemotherapy to tumors while destroying cancerous tissue in […]
Tags: aging, Alzheimer's disease, antibodies, cancer, CAR-T cell therapy, COVID-19, diabetes, gastrointestinal cancer, heart failure, hereditary diseases, News of the Week, opioids
February 3, 2021
Diabetes Powerfully Associated with Premature Coronary Heart Disease in Women
By Advancing the Science contributor
A new biomarker of insulin resistance was tied to a 600 percent increase in risk of premature coronary heart disease By Brigham and Women’s Hospital Press Office BOSTON — While deaths related to heart disease have declined among older people, studies suggest that death rates among younger patients have remained stagnant or increased slightly. To […]
Tags: collaboration, coronary artery disease, diabetes, heart disease, Sagar Dugani, team science
February 2, 2021
Diabetes treatment disparities widespread, room for improvement
More than 34 million people in the U.S. have diabetes, reports the Centers for Disease Control and Prevention. Of these, the vast majority have type 2, or a reduced ability of their bodies to effectively process sugar in foods into energy for life. Most people with type 2 diabetes have multiple considerations – including heart […]
Tags: Center for the Science of Health Care Delivery, Centers for Disease Control and Prevention, diabetes, health care value, health disparities, health equity, heart disease, hypoglycemia, kidney disease, medication management, OptumLabs, pharmacy
February 1, 2021
Mayo Clinic Research in the news — 2/1/2021
Mayo Clinic faculty continue to share their expertise across a broad range of medical and health care topics, including women’s health, concussion, disparities in care, and the never abating COVID-19. Mayo Clinic Indicates Age Has Distinct Influences on Sex-Related Outcomes After Heart Attack Pharmacy Times, 1/27/2021 Researchers at the Mayo Clinic have found ways that […]
Tags: Alex Adjei, Ali Duarte Garcia, breast cancer, CAR-T cell therapy, Centers for Disease Control and Prevention, concussion, COVID-19, depression, diabetes, drug discovery, gene mutation, Grzegorz Nowakowski
January 25, 2021
Mayo Clinic Research in the news — 1/25/2021
From acupuncture, breast cancer, diabetes, euthyroid … all the way to Zika, Mayo Clinic research and experts are featured in the news. Also find COVID-19 observations, advice and findings. The Rochester Epidemiology Project: “The greatest medical resource you’ve never heard of” Rochester Magazine, 1/22/2021 The Rochester Epidemiology Project has changed the way we view ADHD. […]
Tags: acupuncture, acute flaccid myelitis, ADHD, Alzheimer's disease, amyloidosis, artificial intelligence, biomarkers, breast cancer, Brent Bauer, cancer, cancer genomics, cannabidiol (CBD)
December 1, 2020
Could regenerative medicine provide a new approach to diabetes care?
November is National Diabetes Month, a time to reflect on new ways to manage a chronic condition that affects young and old. Mayo Clinic is applying a regenerative lens to advancing diabetes care beyond routine blood checks and standard insulin therapy. Quinn Peterson, Ph.D.; Aleksey Matveyenko, Ph.D.; and Alexander Revzin, Ph.D., are collaborating on a […]
Tags: Aleksey Matveyenko, Alexander Revzin, animal model, cell replacement therapy, Center for Regenerative Medicine, Centers for Disease Control and Prevention, diabetes, Quinn Peterson, stem cells